Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Genome Wide SNP Analysis Reveals Frequent Cryptic Clonal Chromosomal Aberrations Including Uniparental Disomy (UPD) in Waldenstrom's Macroglobulinemia.

Stephanie Poulain, MD, Christophe Roumier, PhD, Meyling Cheok, PhD, Sylvie Zoutina, PhD, Agnes Daudignon, MPharm, Olivier Nibourel, MPharm, Valérie Soenen, MPharm, Jean Luc Lai, PhD, Jose Fernandez, MD, Claude Preudhomme, Patrick Duthilleul, MPharm, Pierre Morel, MD, Xavier Leleu

Blood (2009) 114 (22): 3932.

https://doi.org/10.1182/blood.V114.22.3932.3932

Published: 2009

Journal Articles

Myeloid Cell Differentiation Arrest by Mir-125b-1 in Myelodysplasic Syndrome and Acute Myeloid Leukemia with the T(2;11)(p21;q23) Translocation

Marina Bousquet, Cathy Quelen, Roberto Rosati, Véronique Mansat-De Mas, Christian Bastard, Eric Lippert, Pascaline Talmant, Marina Lafage-Pochitaloff, Dominique Leroux, Carine Gervais, Franck Viguie, Jean-Luc Lai, Christine Terre, Georges Delsol, Nicole Dastugue, Cristina Mecucci, Pierre Brousset

Blood (2008) 112 (11): 4148.

https://doi.org/10.1182/blood.V112.11.4148.4148

Published: 2008

Journal Articles

Prognostic Significance of SALL4 Expression Levels in Paediatric Acute Myeloid Leukaemia (AML).

Paola Ballerini, Pierre-Yves Boelle, Caroline Deswarte, Anne Auvrignon, Gabrielle Couchy, Judith Landman- Parker, Alain Robert, Brigitte Nelken, Mircea Adam, Helene Lapillonne, Eric Delabesse, PhD, Christine Perot, Jean Luc Lai, Nicole Dastugue, Claude Preudhomme, Jessica Zucman-Rossi, Guy Leverger

Blood (2008) 112 (11): 2243.

https://doi.org/10.1182/blood.V112.11.2243.2243

Published: 2008

Journal Articles

RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL + leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance

Catherine Roche-Lestienne, Lauréline Deluche, Sélim Corm, Isabelle Tigaud, Sami Joha, Nathalie Philippe, Sandrine Geffroy, Jean-Luc Laï, Franck-Emmanuel Nicolini, Claude Preudhomme

Blood (2008) 111 (7): 3735–3741.

https://doi.org/10.1182/blood-2007-07-102533

Published: 2008

Includes: Supplemental data

Journal Articles

Prognostic Impact of Cytogenetic Abnormalities in Elderly Patients with Acute Myeloid Leukemia (AML) Enrolled in the ALFA-9803 Trial.

Christine Terré, Claude Gardin, Nathalie Gachard, Isabelle Tigaud, François Désangles, Christian Bastard, Odile Maarek, Jean-Luc Lai, Alain Bernheim, Christine Perot, Florence Nguyen-Khac, Virginie Eclache, Ghislaine Plessis, Pascal Turlure, Xavier Thomas, Thierry de Revel, Pierre Fenaux, Hervé Dombret

Blood (2007) 110 (11): 4233.

https://doi.org/10.1182/blood.V110.11.4233.4233

Published: 2007

Journal Articles

RUNX1 DNA-Binding Mutations and RUNX1-PRDM16 Cryptic Fusion in BCR/ABL+ Leukemias Are Frequently Associated with Secondary Trisomy 21 and May Contribute to Clonal Evolution and Imatinib Resistance.

Catherine Roche-Lestienne, PhD, Laureline Deluche, MD, Selim Corm, MD, Isabelle Tigaud, MD, Sami Joha, PhD, Nathalie Philippe, PhD, Sandrine Geffroy, PhD, Jean-Luc Lai, PhD, Franck Nicolini, MD, PhD, Claude Preudhomme, MD, PhD

Blood (2007) 110 (11): 2786.

https://doi.org/10.1182/blood.V110.11.2786.2786

Published: 2007

Journal Articles

Plasma Cell Proliferation Using Ki67 Antigen Expression Defines Subgroups Related to Short Survival in Multiple Myeloma Especially with Low Beta-2 Microglobulin.

Thomas Gastinne, Xavier Leleu, Anne-Sophie Moreau, Joris Andrieux, Jean-Luc Lai, Valérie Coiteux, Ibrahim Yakoub-Agha, Francis Bauters, Philippe Moreau, Jean-Luc Harousseau, Thierry Facon, Marc Zandecki

Blood (2006) 108 (11): 5031.

https://doi.org/10.1182/blood.V108.11.5031.5031

Published: 2006

Journal Articles

A Retrospective Survey of Imatinib Mesylate Treatment for Chronic Myeloid Leukemia in a Northern France Region.

Selim Corm, MD, Ariane Leroyer, MD, Mathieu Wemeau, MD, Bruno Bregman, PhD, Abderrahim Oukessou, MD, Michiel Hemels, MD, Claude Preudhomme, MD, PhD, Jean-Pierre Jouet, MD, Jean-Luc Lai, PhD, Thierry Facon, MD

Blood (2006) 108 (11): 4800.

https://doi.org/10.1182/blood.V108.11.4800.4800

Published: 2006

Journal Articles

A Retrospective 20-Year Survey of the Incidence of Chronic Myeloid Leukemia in the Northern France Region.

Selim Corm, MD, Ariane Leroyer, MD, Mathieu Wemeau, MD, Bruno Bregman, PhD, Abderrahim Oukessou, MD, Claude Preudhomme, MD, PhD, Jean-Pierre Jouet, MD, Jean-Luc Lai, PhD, Thierry Facon, MD

Blood (2006) 108 (11): 4798.

https://doi.org/10.1182/blood.V108.11.4798.4798

Published: 2006

Journal Articles

ALFA-9000 Trial - An Analysis of Cytogenetic Subsets: Significant Long-Term Benefit of Early Induction Reinforcement Is Observed in CBF-AML Only.

Claude Gardin, Sylvie Chevret, Christiane Charrin, Xavier Thomas, Christian Bastard, Jean-Luc Lai, Odile Maarek, Stephane de Botton, Dominique Bordessoule, Herve Tilly, Thierry de Revel, Christine Terre, Claude Preudhomme, Francis Bauters, Mauricette Michallet, Denis Fiere, Sylvie Castaigne, Pierre Fenaux, Herve Dombret

Blood (2005) 106 (11): 1842.

https://doi.org/10.1182/blood.V106.11.1842.1842

Published: 2005

Journal Articles

Molecular Characterization of the Idiopathic Hypereosinophilic Syndrome (HES) in 35 French Patients with Normal Conventional Cytogenetics.

Catherine Roche-Lestienne, PhD, Valerie Soenen-Cornu, MD, PhD, Jean-Emmanuel Kahn, MD, Jean-Luc Lai, PhD, Eric Hachulla, MD, Francois Drupt, MD, Anne-Laure Demarty, MD, Martine Gardembas, MD, Nathalie Philippe, Stephane Barette, MD, Christian Libersa, MD, PhD, Olivier Bletry, MD, PhD, Christian Rose, MD, PhD, Pierre Fenaux, MD, PhD, Lionel Prin, MD, PhD, Claude Preudhomme, MD, PhD

Blood (2004) 104 (11): 2442.

https://doi.org/10.1182/blood.V104.11.2442.2442

Published: 2004

Journal Articles

Poor Prognosis of Adult Acute Myeloid Leukemia (AML) with High Level of Evi1 and BAALC Transcript.

Valeria Biggio, Selim Corm, MD, Hugues Leroy, MD, Stephane De Botton, MD, Christophe Roumier, MD, Stephane Depil, MD, Nathalie Philippe, Jean-Luc Lai, MD, PHD, Francis Bauters, MD, PHD, Pierre Fenaux, MD, PHD, Claude Preudhomme, MD, PHD

Blood (2004) 104 (11): 2994.

https://doi.org/10.1182/blood.V104.11.2994.2994

Published: 2004

Journal Articles

Does cytogenetic mosaicism in CD34 + CD38 low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?

Chrystèle Bilhou-Nabéra, Christophe Brigaudeau, Denis Clay, Joris Andrieux, Jean-Luc Lai, Danielle Brouty-Boyé, Christine Vignon, Marie-Josée Gharbi, Marie-Caroline Le Bousse-Kerdilès, Vincent Praloran, the members of the French INSERM Network on Myeloid Metaplasia with Myelofibrosis

Blood (2003) 102 (4): 1551–1552.

https://doi.org/10.1182/blood-2003-03-0691

Published: 2003

Journal Articles

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

Blood (2003) 101 (4): 1277–1283.

https://doi.org/10.1182/blood-2002-05-1474

Published: 2003

Journal Articles

High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21

Claude Preudhomme, Delphine Warot-Loze, Christophe Roumier, Nalthalie Grardel-Duflos, Richard Garand, Jean Luc Lai, Nicole Dastugue, Elizabeth Macintyre, Claude Denis, Francis Bauters, Jean Pierre Kerckaert, Alain Cosson, Pierre Fenaux

Blood (2000) 96 (8): 2862–2869.

https://doi.org/10.1182/blood.V96.8.2862

Published: 2000

NARROW

Genome Wide SNP Analysis Reveals Frequent Cryptic Clonal Chromosomal Aberrations Including Uniparental Disomy (UPD) in Waldenstrom's Macroglobulinemia.

Myeloid Cell Differentiation Arrest by Mir-125b-1 in Myelodysplasic Syndrome and Acute Myeloid Leukemia with the T(2;11)(p21;q23) Translocation

Prognostic Significance of SALL4 Expression Levels in Paediatric Acute Myeloid Leukaemia (AML).

RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL + leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance

Prognostic Impact of Cytogenetic Abnormalities in Elderly Patients with Acute Myeloid Leukemia (AML) Enrolled in the ALFA-9803 Trial.

RUNX1 DNA-Binding Mutations and RUNX1-PRDM16 Cryptic Fusion in BCR/ABL+ Leukemias Are Frequently Associated with Secondary Trisomy 21 and May Contribute to Clonal Evolution and Imatinib Resistance.

Plasma Cell Proliferation Using Ki67 Antigen Expression Defines Subgroups Related to Short Survival in Multiple Myeloma Especially with Low Beta-2 Microglobulin.

A Retrospective Survey of Imatinib Mesylate Treatment for Chronic Myeloid Leukemia in a Northern France Region.

A Retrospective 20-Year Survey of the Incidence of Chronic Myeloid Leukemia in the Northern France Region.

ALFA-9000 Trial - An Analysis of Cytogenetic Subsets: Significant Long-Term Benefit of Early Induction Reinforcement Is Observed in CBF-AML Only.

Molecular Characterization of the Idiopathic Hypereosinophilic Syndrome (HES) in 35 French Patients with Normal Conventional Cytogenetics.

Poor Prognosis of Adult Acute Myeloid Leukemia (AML) with High Level of Evi1 and BAALC Transcript.

Does cytogenetic mosaicism in CD34 + CD38 low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis?

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only